CASE NUMBER
1:2019bk11632
1:2019bk11632
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Quarter
| May 20, 2019 | 1 | Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/20/2019) | |
|---|---|---|---|
| May 20, 2019 | Receipt of Voluntary Petition (Chapter 11)( 19-11632) [misc,824] (1717.00) Filing Fee. Receipt number A13218205. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 05/20/2019) | ||
| May 21, 2019 | 2 | Declaration of John R. Castellano in Support of Chapter 11 Petitions and First Day Pleadings filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 3 | Motion for Joint Administration filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 4 | Motion to Appoint Prime Clerk LLC as Claims and Noticing Agent filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 5 | Motion to Authorize / Debtors' Motion for Order: (A) Waiving Requirement for Filing List of Creditors; (B) Authorizing Debtors to File Consolidated List of Creditors; and (C) Authorizing Debtors to Establish Procedures for Notifying Creditors of Commencement of Cases filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 6 | Motion to Authorize / Debtors' Motion for Order Pursuant to Section 105(a) of the Bankruptcy Code (I) Enforcing Protections of Sections 362, 365, 525 and 541 of the Bankruptcy Code, and (II) Approving Notice to Customers, Suppliers and Other Stakeholders of Debtors' Non-Debtor Global Affiliates filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 7 | Motion to Set Last Day to File Proofs of Claim / Debtors' Motion for Order Setting Deadlines to File Proofs of Claim and Approving Form and Manner of Notice Thereof filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 8 | Motion to Authorize / Debtors' Motion for Interim and Final Orders: (A) Authorizing Payment of Certain Prepetition Taxes and Regulatory and Other Fees; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 9 | Motion to Authorize / Debtors' Motion for Interim and Final Orders: (A) Authorizing Debtors to Pay (I) Prepetition Employee Wages, Salaries and Other Compensation, (II) Prepetition Employee Business Expenses, (III) Other Miscellaneous Employee Expenses and Employee Benefits; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 10 | Motion to Authorize / Debtors' Motion for Interim and Final Orders Pursuant to Sections 105(a), 363(b), 503(b) and 507(a) of the Bankruptcy Code Authorizing Debtors to Pay Prepetition Claims of Critical Vendors, Foreign Vendors and Suppliers of Goods Entitled to Administrative Priority filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 11 | Motion to Authorize / Debtors' Motion for Interim and Final Orders: (A) Authorizing Payment of Prepetition Common Carrier, Warehouse, and Freight Forwarder Claims and Related Obligations; and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 12 | Motion to Authorize / Debtors' Motion Pursuant to Sections 105(a), 363(b), 506(a) and 553 of the Bankruptcy Code for Interim and Final Orders: (A) Authorizing Debtors to Honor Certain Prepetition Obligations to Customers and Continue Customer Programs; (B) Authorizing Setoffs Related to Chargebacks in the Ordinary Course of Business; and (C) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 13 | Motion to Authorize / Debtors' Motion for Interim and Final Orders Authorizing: (A) Continued Use of the Debtors' Cash Management System and Procedures; (B) Maintenance and Continued Use of Existing Bank Accounts; (C) Modification of Certain U.S. Trustee Operating Guidelines Relating to Bank Accounts; and (D) Continuation of Intercompany Transactions and Accordance of Administrative Expense Status to Intercompany Claims filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 14 | Motion to Approve Debtor in Possession Financing / Debtors' Motion for Interim and Final Orders: (I) Authorizing Postpetition Financing; (II) Granting Liens, Security Interest and Superpriority Status; (III) Authorizing Use of Cash Collateral; (IV) Affording Adequate Protection; (V) Scheduling a Final Hearing; (VI) Modifying the Automatic Stay; and (VII) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 15 | Motion to Authorize / Debtors' Motion for Order (A) Authorizing Continued Payment of Government Settlement Claims in the Ordinary Course of Business, and (B) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
| May 21, 2019 | 16 | Motion to Authorize / Debtors' Motion for Order (I) Authorizing Assumption of Shared Services Agreements, as Amended, and (II) Granting Related Relief filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) | |
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
|||
This case is closed and is no longer being updated.
| Emmet, Marvin & Martin, LLP |
|---|
| GIBSON, DUNN & CRUTCHER LLP |
| GOODWIN PROCTER LLP |
| LATHAM & WATKINS LLP |
| Matthew J. Williams |
| Office of the United States Trustee |
| Shipman & Goodwin LLP |
| State of Tennessee |
Aegerion Pharmaceuticals, Inc.
245 First Street, Riverview II
18th Floor
Cambridge, MA 02142
MIDDLESEX-MA
United States
Tax ID / EIN: xx-xxx0116
fka Metexion, Inc.
Paul V. Shalhoub
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8764
Fax : (212) 728-8111
Email: maosbny@willkie.com
United States Trustee
Office of the United States Trustee
U.S. Federal Office Building
201 Varick Street, Room 1006
New York, NY 10014
(212) 510-0500
| Date Filed | Name = parent case |
Chapter | Case # |
|---|---|---|---|
| Jun 26, 2023 | FirstSight Group LLC | 7 | 1:2023bk11024 |
| Mar 21, 2023 | Three Companies, LLC | 7 | 1:2023bk10412 |
| Mar 2, 2023 | Ralph T. Centanni, Trustee of the Frederick A. Cen | 11 | 1:2023bk10317 |
| Feb 28, 2023 | Cassandra AMG LLC | 7 | 1:2023bk10292 |
| Feb 27, 2023 | FirstSight B LLC | 7 | 1:2023bk10284 |
| Aug 9, 2021 | Impact Global Education, Inc. | 7 | 1:2021bk11148 |
| Jul 15, 2019 | New England Blazers, LLC | 7 | 1:2019bk12394 |
| May 20, 2019 |
Aegerion Pharmaceuticals Holdings, Inc.
|
11 | 1:2019bk11633 |
| Nov 10, 2016 | 31 Tozer Road, LLC | 11 | 1:16-bk-14309 |
| Jan 30, 2015 | Pathways To Wellness, Inc. | 7 | 1:15-bk-10349 |
| Oct 24, 2014 | Vesy, Inc. | 7 | 1:14-bk-14985 |
| Nov 15, 2012 | Helicos Biosciences Corporation | 11 | 1:12-bk-19091 |
| Nov 7, 2012 | TMC Investors, LLC | 11 | 1:12-bk-13045 |
| Nov 7, 2012 | Monitor Company Group Limited Partnership | 11 | 1:12-bk-13042 |
| Oct 30, 2012 | Inspiration Biopharmaceuticals, Inc. | 11 | 1:12-bk-18687 |
